Acquisition of CrestOptics

Funds of Funds Experts
Lower Mid-Market Experts

We are pleased to announce the acquisition of CrestOptics to Qualitas Funds IV portfolio through our British manager.

Our GP has acquired a majority stake of CrestOptics, world leader in the development and manufacturing of advanced systems for microscopies.

CrestOptics was established in 2010 by a team of highly experience engineers and designers to build and commercialise a new microscopy technology. Their products are important for advanced biological and medical research, such as in the field of cancer and neuroscience, and offer technical advantages compared to competitors at more accessible prices.

The investment is based on:

  • CrestOptics generated over €5M revenues in 2020
  • The companys´ leading technology
  • The global customer base and product distribution
  • Innovative product pipelines
  • Strong organic growth prospect that could be catalysed by M&A
  • Competent and ambitious management team and incoming chairman with proven excellence along the industry